Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins.
| Image |  |
|---|---|
| Description | scientific article published on 8 January 2016 |
| Author/s |
author: Irem Durmaz Rengul Cetin-Atalay |
| Publication date | January 8, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |